Seoul, South Korea

Jung Taek Kang

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Hanwha Advanced Materials Corporation, Snu Rdb Foundation. Active years: 2015-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jung Taek Kang. Retrieved from https://idiyas.com/inventor/jung-taek-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jung Taek Kang: Innovator in Transgenic Technologies

Introduction

Jung Taek Kang is a notable inventor hailing from Seoul, South Korea. With a focus on advanced genetic engineering, he has made significant contributions to the field of biomedicine through his innovative inventions. To date, he holds two patents that highlight his dedication to improving organ transplantation and immune response management.

Latest Patents

Jung Taek Kang's latest patents have paved the way for advancements in the creation of transgenic pigs. His first patent, titled "Transgenic pig expressing sTNFR1-Fc genes and the uses thereof," introduces a transgenic pig that expresses the sTNFR1-Fc gene. This gene encodes a fusion protein designed to suppress immune and inflammatory responses by managing TNF-α activity in the blood. The implications of this invention are far-reaching, offering potential solutions for xenograft procedures. Notably, this pig has a blood type of O, allowing for its use in transplants without regard to the recipient's blood type.

His second patent, "Transgenic pig in which HO-1 and TNFR1-Fc are simultaneously expressed, and method for producing same," further innovates the field by revealing a method to inhibit immune rejection responses through the simultaneous expression of human HO-1 and TNFR1-Fc genes in a transgenic pig. This breakthrough has significant applications in organ transplantation, leading to more compatible donor organs and better outcomes for recipients.

Career Highlights

Throughout his career, Jung Taek Kang has worked with prominent organizations, including Hanwha Advanced Materials Corporation and the Snur & Db Foundation. His experiences in these companies have contributed to his remarkable skill set and understanding of innovative biotechnological applications.

Collaborations

Collaboration plays a vital role in advancing technologies, and Jung Taek Kang has worked alongside esteemed colleagues, including Curie Ahn and Byeong Chun Lee. Their combined expertise has further strengthened the research and development of groundbreaking inventions in the realm of transgenic technologies.

Conclusion

Jung Taek Kang stands out as a visionary inventor in the field of transgenic research. His innovative patents and collaborative efforts demonstrate a commitment to enhancing medical science and improving the lives of patients needing organ transplants. Through his pioneering work, he is paving the way for future advancements in biotechnology and transplantation medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…